Norway's Crown Princess Mette-Marit Undergoes Successful Lung Transplant for Pulmonary Fibrosis
核心洞察
Crown Princess Mette-Marit of Norway, 52, has undergone a successful lung transplant at Rikshospitalet (搜索) in Oslo, the royal house announced Wednesday.
She was diagnosed in 2018 with pulmonary fibrosis (搜索), a progressive disease that damages and scars lung tissue, causing serious breathing problems with no known cure.
The head of the hospital's pulmonary department, Are Holm, said "we are very pleased that everything has gone well so far," noting she will remain hospitalized for several weeks.
Crown Princess Mette-Marit of Norway has undergone a successful lung transplant at Rikshospitalet (搜索) in Oslo, the country's royal house announced Wednesday. The 52-year-old was diagnosed in 2018 with pulmonary fibrosis (搜索), a progressive disease that damages and scars lung tissue, which can cause serious breathing problems and for which there is no known cure.
Earlier this month, the royal house announced that she had been placed on a lung transplant list. On Wednesday, it said in a statement that she had received a transplant at the Rikshospitalet (搜索) in Oslo.
Clinical Course and Prognosis
The head of the hospital's pulmonary department, Are Holm, said in the statement that "we are very pleased that everything has gone well so far." Like other transplant recipients, she will remain in the hospital for "several weeks," Holm said. He added that "this is standard procedure to adjust medications, manage any complications and conduct rehabilitation."
Mette-Marit's condition worsened over recent months, coinciding with a challenging period for her on other fronts. The royal house said Crown Prince Haakon, the heir to the Norwegian throne, will "adjust his schedule" to be with his wife during that period. It said that it plans its next update on her health when she is discharged from the hospital.
Disease Background
Pulmonary fibrosis (搜索) is a progressive disease that damages and scars lung tissue. It can cause serious breathing problems, and there is no known cure. The condition led to Mette-Marit being placed on a lung transplant list earlier this month, reflecting the advanced nature of her disease and the limited treatment options available for patients with progressive pulmonary fibrosis.